Ajanta Pharma Q2 FY27 Earnings and Board Meeting Highlights

30 October 2026, 07:27 UTC

Ajanta Pharma Ltd approves Q2 FY27 results, with revenue up 33% YoY to ₹1,794 crore

Adjusted EBITDA, excluding forex loss, rose 47% YoY to ₹543 crore, a 30% margin.
Net profit increased 49% YoY to ₹388 crore.
Auditors issued unmodified limited-review conclusions; no exceptional item was identified.

This is an automated summary of a public document. Always check the original before relying on it.